Biosidus Overview

  • Year Founded
  • 1983

Year Founded

  • Status
  • Private

  • Employees
  • 363

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 2

Biosidus General Information

Description

Manufacturer of biosimilar pharmaceuticals based in Buenos Aires, Argentina. The company specializes in pharmaceutical ingredients along with therapeutic proteins that focus on the treatment of chronic renal failure, cancer, multiple sclerosis, growth hormone deficiency and osteoporosis as well as develops technological platforms in transgenic animals, gene therapy and biodiversity and undertakes the operations of aseptic filling, lyophilization and tablet packing through extensive research and development, bacterial fermentation and massive cell culture, enabling a greater number of patients to have access to biological treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Constitucion 4234
  • Buenos Aires, C1254ABX
  • Argentina
+54 011
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Constitucion 4234
  • Buenos Aires, C1254ABX
  • Argentina
+54 011

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biosidus Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biosidus‘s full profile, request access.

Request a free trial

Biosidus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of biosimilar pharmaceuticals based in Buenos Aires, Argentina. The company specializes in pharmaceutical i
Pharmaceuticals
Buenos Aires, Argentina
363 As of 2021

Parsippany, NJ
 

Framingham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biosidus Competitors (85)

One of Biosidus’s 85 competitors is IVERIC bio, a Formerly VC-backed company based in Parsippany, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
IVERIC bio Formerly VC-backed Parsippany, NJ
Xenetic Bioscience Corporation Framingham, MA
GlobeImmune Formerly VC-backed Louisville, CO
Dermavant Sciences Formerly PE-Backed Long Beach, CA
TheraSource Corporation Manhasset, NY
You’re viewing 5 of 85 competitors. Get the full list »

Biosidus Patents

Biosidus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-7022326-B1 Derived from the tat protein of hiv-1; biological inactive but preserve their immunogenicity; a fusion protein comprising a retroviral regulatory protein fused to a heterologous polypeptide; biodrugs or vaccines for preventing retroviral infections Inactive 26-Dec-1997

Biosidus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biosidus Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biosidus‘s full profile, request access.

Request a free trial

Biosidus FAQs

  • When was Biosidus founded?

    Biosidus was founded in 1983.

  • Where is Biosidus headquartered?

    Biosidus is headquartered in Buenos Aires, Argentina.

  • What is the size of Biosidus?

    Biosidus has 363 total employees.

  • What industry is Biosidus in?

    Biosidus’s primary industry is Pharmaceuticals.

  • Is Biosidus a private or public company?

    Biosidus is a Private company.

  • What is Biosidus’s current revenue?

    The current revenue for Biosidus is .

  • Who are Biosidus’s investors?

    ACON Investments has invested in Biosidus.

  • Who are Biosidus’s competitors?

    IVERIC bio, Xenetic Bioscience, GlobeImmune, Dermavant Sciences, and TheraSource are some of the 85 competitors of Biosidus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »